Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01972139 · ClinicalTrials.gov registry record · NA
Renal Denervation in Patients With Uncontrolled Hypertension - SYMPLICITY HTN-4
A NA study, sponsored by Medtronic Vascular.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT01972139 is a NA study that has completed, run by Medtronic Vascular. The registered enrollment target is 44 participants.
The verdict
NCT01972139, a NA study, has completed, sponsored by Medtronic Vascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
An international, multi-center, prospective, blinded, randomized, controlled trial. The objective is to demonstrate that catheter-based renal denervation is an effective and safe treatment for uncontrolled hypertension.
Interventions
- DEVICE Renal Angiography
- DEVICE Renal Denervation using the Symplicity Renal Denervation System
- OTHER Sham Renal Denervation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2013-10 |
| Est. Completion | 2017-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01972139
The ClinicalTrials.gov registry entry for NCT01972139 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Vascular, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Renal Angiography is the first listed.
NCT01972139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01972139 about?
NCT01972139 is a clinical study titled "Renal Denervation in Patients With Uncontrolled Hypertension - SYMPLICITY HTN-4". An international, multi-center, prospective, blinded, randomized, controlled trial. The objective is to demonstrate that catheter-based renal denervation is an effective and safe treatment for uncontrolled hypertension.
What is the current status of trial NCT01972139?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2013-10. Estimated completion is 2017-01.
What interventions are being tested in trial NCT01972139?
The interventions under investigation include: Renal Angiography (DEVICE), Renal Denervation using the Symplicity Renal Denervation System (DEVICE), Sham Renal Denervation (OTHER).
Who is sponsoring clinical trial NCT01972139?
This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.